Globus Medical Financials

GMED Stock  USD 53.64  0.58  1.09%   
Based on the analysis of Globus Medical's profitability, liquidity, and operating efficiency, Globus Medical may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At present, Globus Medical's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 320.6 M, whereas Current Deferred Revenue is forecasted to decline to about 9.6 M. Key indicators impacting Globus Medical's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Net Profit Margin0.07440.0783
Notably Down
Slightly volatile
Return On Assets0.0230.0242
Notably Down
Slightly volatile
Return On Equity0.02920.0307
Notably Down
Slightly volatile
Debt Equity Ratio0.110.1074
Fairly Up
Slightly volatile
Operating Income153.7 M133.1 M
Fairly Up
Slightly volatile
Current Ratio7.284.8818
Way Up
Slightly volatile
The financial analysis of Globus Medical is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Globus Medical includes many different criteria found on its balance sheet. For example, investors should never minimize Globus Medical's ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Globus Medical's cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Globus Medical.

Net Income

117.3 Million

With this module, you can analyze Globus financials for your investing period. You should be able to track the changes in Globus Medical individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past Globus Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Globus Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Globus Medical's assets may result in an increase in income on the income statement.
Evaluating Globus Medical's financials involves analyzing a range of financial metrics and ratios to gain insights into the company's financial health and performance. However, considering all of Globus Medical's profitability, liquidity ratios, and efficiency indicators at the same time could be an enormous task, and our Financial Distress score can provide you with a snapshot of the Globus Medical's relative financial performance

Chance Of Distress

Less than 9

 
100  
 
Zero
Low
Globus Medical has less than 9 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Globus Medical stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
Please note, Globus Medical's odds of distress score SHOULD NOT be confused with the real chance of Globus Medical filing for bankruptcy protection for chapters 7, 11, 12, or 13. We define Financial Distress as an operational condition where an entity such as Globus is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from public financial statements and analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors considered include Globus Medical's liquidity analysis, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
More Info
The data published in Globus Medical's official financial statements usually reflect Globus Medical's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Globus Medical. For example, before you start analyzing numbers published by Globus accountants, it's critical to develop an understanding of what Globus Medical's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Globus Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Globus Medical's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Globus Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Globus Medical. Please utilize our Beneish M Score to check the likelihood of Globus Medical's management manipulating its earnings.

Globus Medical Company Summary

Globus Medical competes with Spectral, Medigus, Outset MedicalInc, Monogram Orthopaedics, and Venus Concept. Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. Globus Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 2400 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNew York Stock Exchange
CIK Number0001237831
ISINUS3795772082
CUSIP379577208
RegionNorth America
LocationPennsylvania; U.S.A
Business Address2560 General Armistead
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkNYSE Composite
Websitewww.globusmedical.com
Phone610 930 1800
CurrencyUSD - US Dollar
You should never invest in Globus Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Globus Stock, because this is throwing your money away. Analyzing the key information contained in Globus Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Globus Medical Key Financial Ratios

Generally speaking, Globus Medical's financial ratios allow both analysts and investors to convert raw data from Globus Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Globus Medical over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Globus Medical reports annually and quarterly.

Globus Medical Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets1.5B1.7B2.0B2.1B5.1B5.3B
Other Current Liab6.7M5.8M11.8M106.5M305.3M320.6M
Other Liab17.1M52.4M75.7M70.5M81.1M85.2M
Net Debt(193.2M)(234.6M)(188.0M)(144.5M)53.1M55.8M
Retained Earnings1.0B1.0B1.2B1.2B1.1B764.6M
Accounts Payable24.6M18.2M22.0M36.1M56.7M59.5M
Cash195.7M239.4M193.1M150.5M467.3M490.7M
Other Assets25.2M209.8M60.8M92.2M106.0M111.3M
Net Receivables162.4M148.1M165.7M217.3M504.9M530.1M
Inventory196.3M229.2M237.0M299.0M848.1M890.5M
Other Current Assets17.2M17.8M18.4M21.0M44.6M46.8M
Total Liab129.6M173.2M215.9M229.8M1.1B1.1B
Total Current Assets687.5M821.8M864.5M983.3M1.9B2.0B
Short Term Debt74.7M88.7M94.4M2.5M12.0M11.4M
Good Will128.8M156.7M179.7M197.5M1.4B1.5B
Intangible Assets78.8M86.9M68.7M63.6M924.6M970.8M
Net Tangible Assets1.2B1.3B1.5B1.6B1.8B981.4M
Capital Surpluse357.3M457.2M553.8M631.0M725.6M761.9M

Globus Medical Key Income Statement Accounts

An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket. The other reason investors look at the income statement is to determine what Globus Medical's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
201920202021202220232024 (projected)
Interest Expense17.4M14.0M9.3M14.2M20.1M21.1M
Total Revenue785.4M789.0M958.1M1.0B1.6B1.6B
Gross Profit605.4M571.6M718.9M759.1M1.0B533.4M
Operating Income172.0M111.4M172.0M228.0M133.1M153.7M
Ebit172.0M111.4M172.0M228.0M256.3M168.5M
Research Development60.1M84.5M97.3M73.0M124.0M130.2M
Ebitda230.0M182.7M289.1M313.8M401.0M221.9M
Cost Of Revenue180.0M217.5M239.2M263.7M548.2M575.6M
Income Before Tax189.9M125.9M180.4M243.0M165.4M162.4M
Net Income155.2M102.3M149.2M190.2M122.9M117.3M
Income Tax Expense34.7M23.6M31.2M52.9M42.5M44.9M
Tax Provision34.7M23.6M31.2M52.9M42.5M34.9M
Net Interest Income17.4M14.0M9.3M14.2M20.1M13.5M

Globus Medical Key Cash Accounts

Cash flow analysis captures how much money flows into and out of Globus Medical. It measures of how well Globus is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Globus Medical brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Globus had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Globus Medical has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
201920202021202220232024 (projected)
Change To Inventory(50.0M)(50.1M)(12.0M)(61.7M)(70.3M)(66.8M)
Change In Cash56.0M43.7M(46.3M)(42.6M)316.8M332.7M
Free Cash Flow101.2M135.1M219.4M104.4M165.2M106.5M
Depreciation52.7M62.9M69.9M68.3M144.7M152.0M
Other Non Cash Items7.1M48.5M61.5M14.7M97.5M102.4M
Capital Expenditures70.8M63.7M56.9M74.0M78.3M49.9M
Net Income155.2M102.3M149.2M190.2M122.9M117.5M
End Period Cash Flow195.7M239.4M193.1M150.5M467.3M490.7M
Change To Netincome37.5M71.3M71.9M22.6M26.0M34.2M
Investments(45.7M)(20.2M)(284.6M)(4.9M)(78.1M)(82.0M)

Globus Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Globus Medical's current stock value. Our valuation model uses many indicators to compare Globus Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Globus Medical competition to find correlations between indicators driving Globus Medical's intrinsic value. More Info.
Globus Medical is rated # 5 in beta category among related companies. It is rated # 4 in price to sales category among related companies fabricating about  4.21  of Price To Sales per Beta. The current year's Price To Sales Ratio is expected to grow to 4.16. Comparative valuation analysis is a catch-all model that can be used if you cannot value Globus Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Globus Medical's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Globus Medical's earnings, one of the primary drivers of an investment's value.

Globus Medical Systematic Risk

Globus Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Globus Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Globus Medical correlated with the market. If Beta is less than 0 Globus Medical generally moves in the opposite direction as compared to the market. If Globus Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Globus Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Globus Medical is generally in the same direction as the market. If Beta > 1 Globus Medical moves generally in the same direction as, but more than the movement of the benchmark.

About Globus Medical Financials

What exactly are Globus Medical Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Globus Medical's income statement, its balance sheet, and the statement of cash flows. Potential Globus Medical investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Globus Medical investors may use each financial statement separately, they are all related. The changes in Globus Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Globus Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Steps to analyze Globus Medical Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Globus Medical is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Globus has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Globus Medical's financials are consistent with your investment objective using the following steps:
  • Review Globus Medical's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Globus Medical's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Globus Medical's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Globus Medical's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Globus Medical Thematic Clasifications

Globus Medical is part of several thematic ideas from Obamacare to Baby Boomer Prospects. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Today, most investors in Globus Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Globus Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Globus Medical growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(1.22)

At present, Globus Medical's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.

Globus Medical March 29, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Globus Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Globus Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Globus Medical based on widely used predictive technical indicators. In general, we focus on analyzing Globus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Globus Medical's daily price indicators and compare them against related drivers.
When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.
Note that the Globus Medical information on this page should be used as a complementary analysis to other Globus Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Globus Stock analysis

When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
CEOs Directory
Screen CEOs from public companies around the world
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Is Globus Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.79)
Earnings Share
1.07
Revenue Per Share
13.87
Quarterly Revenue Growth
1.246
Return On Assets
0.0477
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.